News

Experimental drug Ulefnersen shows potential in halting and even reversing symptoms in patients with FUS- Amyotrophic lateral ...
May is ALS Awareness Month, and in honor of the campaign, ABC 7 New York profiles one well-known New Yorker who's finding a way to make a difference while battling the disease. ALS stands for ...
In-home care can be the most preferred option for patients with progressive diseases such as amyotrophic lateral sclerosis ...
Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that the USFDA has granted ‘Fast Track ...
On June 2, supporters across the U.S. will recognize the legacy of legendary baseball player Lou Gehrig and his impact on ALS ...
Genetic mutations in many forms of ALS lead to early problems with the transport and function of mitochondria, a study found.
Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated ...
Melissa Diaz-Viera and her husband Robert Lang were overjoyed to have a baby after years of trying to get pregnant and also ...
Scientists from St. Jude Children's Research Hospital and Washington University in St. Louis report mechanistic insights into ...
Scientists found that stabilizing stress granules suppresses the effects of ALS-causing mutations, correcting previous models that imply stress granules promote amyloid formation.
Experimental drug Ulefnersen shows potential in halting and even reversing symptoms in patients with FUS- Amyotrophic lateral sclerosis (ALS) mutation One patient regained full motor function ...